tradingkey.logo

Bone Biologics Corp

BBLG

2.680USD

-0.050-1.83%
Market hours ETQuotes delayed by 15 min
8.77MMarket Cap
LossP/E TTM

Bone Biologics Corp

2.680

-0.050-1.83%
More Details of Bone Biologics Corp Company
Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
Company Info
Ticker SymbolBBLG
Company nameBone Biologics Corp
IPO dateNov 27, 2015
CEOMr. Jeffrey Frelick
Number of employees2
Security typeOrdinary Share
Fiscal year-endNov 27
Address2 Burlington Woods Dr Ste 100
CityBURLINGTON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code01803-4551
Phone17815524452
Websitehttps://www.bonebiologics.com/
Ticker SymbolBBLG
IPO dateNov 27, 2015
CEOMr. Jeffrey Frelick
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Jul 8
Updated: Tue, Jul 8
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Intracoastal Capital, L.L.C.
9.25%
Geode Capital Management, L.L.C.
0.25%
Sabby Management, LLC
0.10%
Frelick (Jeffrey)
0.02%
Walsh (Deina H)
0.02%
Other
90.35%
Shareholders
Shareholders
Proportion
Intracoastal Capital, L.L.C.
9.25%
Geode Capital Management, L.L.C.
0.25%
Sabby Management, LLC
0.10%
Frelick (Jeffrey)
0.02%
Walsh (Deina H)
0.02%
Other
90.35%
Shareholder Types
Shareholders
Proportion
Corporation
9.25%
Investment Advisor/Hedge Fund
0.35%
Individual Investor
0.04%
Hedge Fund
0.02%
Other
90.33%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
26
155.16K
9.67%
+120.59K
2025Q1
27
6.66K
1.22%
-34.55K
2024Q4
36
139.64K
4.27%
-177.16K
2024Q3
35
174.78K
6.98%
-106.17K
2024Q2
34
138.99K
16.02%
-43.94K
2024Q1
34
123.42K
15.56%
-19.42K
2023Q4
32
43.06K
6.51%
-99.40K
2023Q3
31
101.95K
29.59%
-11.73K
2023Q2
29
107.23K
61.29%
+36.20K
2023Q1
27
41.68K
59.89%
-1.33K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Intracoastal Capital, L.L.C.
148.50K
9.25%
+148.50K
--
Jun 27, 2025
Geode Capital Management, L.L.C.
4.03K
0.25%
+1.48K
+57.64%
Mar 31, 2025
Sabby Management, LLC
1.65K
0.1%
+1.65K
--
Dec 31, 2023
Frelick (Jeffrey)
359.00
0.02%
+3.00
+0.84%
Apr 11, 2025
Walsh (Deina H)
313.00
0.02%
--
--
Apr 11, 2025
Tower Research Capital LLC
304.00
0.02%
-261.00
-46.19%
Mar 31, 2025
BofA Global Research (US)
4.00
0%
+1.00
+33.33%
Mar 31, 2025
Meikle (Phillip Terry II)
2.00
0%
--
--
Apr 11, 2025
HRT Financial LP
--
0%
-2.44K
-100.00%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Jun 06, 2023
Merger
30<1
Jun 06, 2023
Merger
30<1
Date
Type
Ratio
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Jun 06, 2023
Merger
30<1
Jun 06, 2023
Merger
30<1
Jun 06, 2023
Merger
30<1
Jun 06, 2023
Merger
30<1
KeyAI